Clinical trial
NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis
NCT02801682 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis
- Lead sponsor
- Medical University of Graz
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2016
- Completion date
- August 31, 2021
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
invasive candidiasis